MCRB

NASDAQStock

Seres Therapeutics, Inc.

$8.66-0.39 (-4.31%)

52-Week Range

$6.77
$28.63

Key Stats

Market Cap

P/E Ratio

Dividend Yield

Beta

0.29

Volume

31.3K

Avg Volume

49.6K

Performance

1M

+10.10%

3M

-43.08%

6M

-42.32%

YTD

-40.26%

1Y

-34.40%

3Y

-92.20%

5Y

-97.94%

Price Chart

ETF Exposure

MCRB is held by 15 ETFs

ETFFund NameWeight
STSBiShares Factors US Small Blend Style ETF0.08%
IWCiShares Micro-Cap ETF0.01%
EESWisdomTree U.S. SmallCap Fund0.01%
PRFZInvesco RAFI US 1500 Small-Mid ETF0.01%
AVSCAvantis U.S. Small Cap Equity ETF0.00%
AVUVAvantis U.S. Small Cap Value ETF0.00%
SCHASchwab U.S. Small-Cap ETF0.00%
VXFVanguard Extended Market ETF0.00%
AVUSAvantis U.S. Equity ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%

About MCRB ETF Exposure

Seres Therapeutics, Inc. (MCRB) is held by 15 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $8.66. Investors can gain exposure to MCRB through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold MCRB, sorted by portfolio weight.